Pigmentation due to a new antitumor agent. Effects of topical application of BCNU [1,3-bis(2-chloroethyl)-1-nitrosourea].
D000287:Administration, Topical; D000970:Antineoplastic Agents / Q000494:pharmacology*; D002330:Carmustine / Q000494:pharmacology*; D004295:Dihydroxyphenylalanine / Q000494:pharmacology; D004890:Erythema / Q000139:chemically induced; D006801:Humans; D008027:Light; D008544:Melanocytes / Q000187:drug effects / Q000473:pathology; D010328:Patch Tests; D012867:Skin / Q000187:drug effects / Q000473:pathology / Q000528:radiation effects; D012880:Skin Pigmentation / Q000187:drug effects*
D000970:Antineoplastic Agents; D004295:Dihydroxyphenylalanine; D002330:Carmustine